Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
about
Promising new treatments for psoriasisTargeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitisAlefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implicationsIL-20: a new target for the treatment of inflammatory skin disease.Novel biological immunotherapies for psoriasis.Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases.Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.T cell targeted immunotherapy for autoimmune disease.Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Roles of CD48 in regulating immunity and tolerance.Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.Aplastic anemia: immunosuppressive therapy in 2010.Targeting memory T cells in type 1 diabetes.Tolerance induction after organ transplantation, "delayed tolerance," via the mixed chimerism approach: planting flowers in a battle field.Diabetes: Immunotherapy for T1DM--still not there yet.Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension
P2860
Q24598008-AECA164F-0AF4-427E-9471-85A56977A578Q24685784-B99F3A89-2A7A-4E8F-97A4-7903F49D0211Q33881015-174BC0FD-4E2B-4FDF-9507-F69F3C2AFA01Q33993967-35A6FACD-5F65-4A60-AC15-243D4D87BE16Q34099814-C98ED77A-8CFF-40F7-A4C1-5BF7900ED0D5Q35095128-80D272CF-5B34-407E-B161-10EF64074B77Q35164740-5B678BFC-E978-414F-9C91-ACBF39AC3B01Q35581131-0648F640-9422-4416-AB19-CFF391538721Q35911103-4AA731C1-36FF-46EE-9CBA-8176B4919658Q36216535-A074CF72-2D9E-4772-9E99-8DB607732E3FQ36356951-87BAA5FE-3836-4351-BDA1-32770596B483Q36359571-2F8D4AB1-325F-4086-A7FC-DC260AF4888DQ36575860-A20D7965-2CB5-4EEA-9AFD-3A10F0E4DDABQ36827134-14A17644-B117-4FC1-9F0E-83A85A3333EBQ36883146-AFD221AB-328F-4330-A3E6-393937FA28F7Q37006155-3DC23FFA-F9FA-4593-B01B-F8FE1F8AB6A1Q37642554-7145937F-4D24-49DC-BE0F-FE23FD2AD54CQ37952705-40336476-103C-4941-AB0A-583E4E076C6BQ38586890-826C85A8-E96F-471D-8689-36726F1483C0Q42190625-E1F8D7F3-F138-4CA5-8AED-8F6DDE6A4FC1Q43713917-80ACBBAC-F77D-4E65-A84E-EE9504655837Q46888800-DCC0CBB0-76F8-4150-B62F-A4AAEF1E87DBQ58434874-A7B8D7F0-E043-47DB-9668-8AA831FC0C22
P2860
Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selective targeting of T cell ...... mittive therapy for psoriasis.
@ast
Selective targeting of T cell ...... mittive therapy for psoriasis.
@en
Selective targeting of T cell ...... mittive therapy for psoriasis.
@nl
type
label
Selective targeting of T cell ...... mittive therapy for psoriasis.
@ast
Selective targeting of T cell ...... mittive therapy for psoriasis.
@en
Selective targeting of T cell ...... mittive therapy for psoriasis.
@nl
prefLabel
Selective targeting of T cell ...... mittive therapy for psoriasis.
@ast
Selective targeting of T cell ...... mittive therapy for psoriasis.
@en
Selective targeting of T cell ...... mittive therapy for psoriasis.
@nl
P2860
P356
P1476
Selective targeting of T cell ...... mittive therapy for psoriasis.
@en
P2093
Gerald G Krueger
P2860
P304
P356
10.1517/14712598.2.4.431
P407
P577
2002-04-01T00:00:00Z